UBS Group’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
UBS Group's OGN Position: Q3 2026 in Review
UBS Group reduced its Organon & Co (OGN) stake by 8.4% in Q3 2026, selling an estimated $5.53M and leaving 4,450,913 shares worth $61M. The position accounts for 0.01% of the portfolio, ranked #1510.
UBS Group first reported a position in OGN in Q2 2021 and has held it in 22 quarters since. The position peaked at $65.8M in Q2 2026. 359 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- UBS Group held 4,450,913 shares of Organon & Co worth $61M as of Q3 2026.
- UBS Group sold 405,616 Organon & Co shares in Q3 2026, an estimated $5.53M.
- Organon & Co made up 0.01% of UBS Group's portfolio in Q3 2026, its #1510 holding.
- UBS Group first reported a position in Organon & Co in Q2 2021 and has held it in 22 quarters since.
- UBS Group's Organon & Co position peaked at $65.8M in Q2 2026.
- 359 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.